Environmental risk factors for inflammatory bowel diseases: Evidence based literature review
- PMID: 27468219
- PMCID: PMC4945988
- DOI: 10.3748/wjg.v22.i27.6296
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review
Abstract
Aim: Advances in genetics and immunology have contributed to the current understanding of the pathogenesis of inflammatory bowel diseases (IBD).
Methods: The current opinion on the pathogenesis of IBD suggests that genetically susceptible individuals develop intolerance to dysregulated gut microflora (dysbiosis) and chronic inflammation develops as a result of environmental insults. Environmental exposures are innumerable with varying effects during the life course of individuals with IBD. Studying the relationship between environmental factors and IBD may provide the missing link to increasing our understanding of the etiology and increased incidence of IBD in recent years with implications for prevention, diagnosis, and treatment. Environmental factors are heterogeneous and genetic predisposition, immune dysregulation, or dysbiosis do not lead to the development of IBD in isolation.
Results: Current challenges in the study of environmental factors and IBD are how to effectively translate promising results from experimental studies to humans in order to develop models that incorporate the complex interactions between the environment, genetics, immunology, and gut microbiota, and limited high quality interventional studies assessing the effect of modifying environmental factors on the natural history and patient outcomes in IBD.
Conclusion: This article critically reviews the current evidence on environmental risk factors for IBD and proposes directions for future research.
Keywords: Environmental factors; Exposomes; Inflammatory bowel disease.
Figures
Similar articles
-
Environment and the inflammatory bowel diseases.Can J Gastroenterol. 2013 Mar;27(3):e18-24. doi: 10.1155/2013/102859. Can J Gastroenterol. 2013. PMID: 23516681 Free PMC article. Review.
-
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.Gastroenterology. 2017 Feb;152(2):398-414.e6. doi: 10.1053/j.gastro.2016.10.019. Epub 2016 Oct 25. Gastroenterology. 2017. PMID: 27793606
-
The Search for Causative Environmental Factors in Inflammatory Bowel Disease.Dig Dis. 2016;34 Suppl 1:48-55. doi: 10.1159/000447283. Epub 2016 Aug 22. Dig Dis. 2016. PMID: 27548430
-
Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.Nutrients. 2017 Aug 30;9(9):962. doi: 10.3390/nu9090962. Nutrients. 2017. PMID: 28867793 Free PMC article. Review.
-
Westernized Diet is the Most Ubiquitous Environmental Factor in Inflammatory Bowel Disease.Perm J. 2019;23:18-107. doi: 10.7812/TPP/18-107. Perm J. 2019. PMID: 30624192 Free PMC article.
Cited by
-
Prenatal Immunity and Influences on Necrotizing Enterocolitis and Associated Neonatal Disorders.Front Immunol. 2021 Apr 21;12:650709. doi: 10.3389/fimmu.2021.650709. eCollection 2021. Front Immunol. 2021. PMID: 33968047 Free PMC article. Review.
-
Crohn's disease: an update.Clin Med (Lond). 2023 Nov;23(6):549-557. doi: 10.7861/clinmed.2023-0493. Clin Med (Lond). 2023. PMID: 38065612 Free PMC article.
-
Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID).Nutrients. 2021 Mar 25;13(4):1067. doi: 10.3390/nu13041067. Nutrients. 2021. PMID: 33806061 Free PMC article. Review.
-
Global alteration of colonic microRNAome landscape associated with inflammatory bowel disease.Front Immunol. 2022 Sep 13;13:991346. doi: 10.3389/fimmu.2022.991346. eCollection 2022. Front Immunol. 2022. PMID: 36177008 Free PMC article.
-
Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease.J Crohns Colitis. 2018 Aug 29;12(9):1021-1029. doi: 10.1093/ecco-jcc/jjy049. J Crohns Colitis. 2018. PMID: 29767728 Free PMC article. Clinical Trial.
References
-
- Russell RK, Satsangi J. Does IBD run in families? Inflamm Bowel Dis. 2008;14 Suppl 2:S20–S21. - PubMed
-
- Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603. - PubMed
-
- Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14:1847–1850. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources